Lichen clinical trials

Explore recruiting lichen clinical trials.

Recruiting lichen studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lichen trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Proof of concept study (multicenter, phase II) on the efficacy of the selective TYK2 inhibitor Deucravacitinib in Lichen planus patients (DEUCRALIP)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Upadacitinib in adult patients with erosive mucosal Lichen Planus and Lichen Planopilaris: a prospective multicenter randomized placebo-controlled study. (Upa30-LP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice-daily Delgocitinib Cream in Adult Participants with Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

MERCURE study: MEthotrexate in ReCurrent dVIN

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

Greece, Germany, Spain, Italy, Hungary, Belgium +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A parallel group (2-arm), randomised, double-blind, 12-week trial to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women diagnosed with vulvar lichen sclerosus (VLS)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Lichen trials by city

Lichen in Toronto Lichen in Vancouver Lichen in Montreal Lichen in Calgary Lichen in Edmonton Lichen in Ottawa Lichen in Winnipeg Lichen in Quebec City Lichen in Hamilton Lichen in Kitchener Lichen in London Lichen in Halifax Lichen in New York Lichen in Los Angeles Lichen in Chicago Lichen in Houston

Lichen clinical trials

Recruiting lichen studies right now

Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment

To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.

Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus

Also recruiting in Europe

Proof of concept study (multicenter, phase II) on the efficacy of the selective TYK2 inhibitor Deucravacitinib in Lichen planus patients (DEUCRALIP)

Upadacitinib in adult patients with erosive mucosal Lichen Planus and Lichen Planopilaris: a prospective multicenter randomized placebo-controlled study. (Upa30-LP)

A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice-daily Delgocitinib Cream in Adult Participants with Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period

MERCURE study: MEthotrexate in ReCurrent dVIN

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

A parallel group (2-arm), randomised, double-blind, 12-week trial to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women diagnosed with vulvar lichen sclerosus (VLS)

Lichen trials by city

Other conditions